Prof. Dr. Dr. Stefanie Corradini

Lehrstuhl für Strahlentherapie Department of Radiation Oncology

Targeted RT study: results on early toxicity of targeted therapies and radiotherapy (2024) Konnerth D, Gaasch A, Westphalen CB, Heinrich K, Niyazi M, Eze C, Rogowski P, et al. Journal article Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer (2024) Haussmann J, Budach W, Nestle-Krämling C, Wollandt S, Jazmati D, Tamaskovics B, Corradini S, et al. Journal article Advances in breast cancer treatment: a systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer (2024) Bilski M, Konat-Bąska K, Zerella MA, Corradini S, Hetnał M, Leonardi MC, Gruba M, et al. Journal article, Review article Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac (2024) Rabe M, Dietrich O, Forbrig R, Niyazi M, Belka C, Corradini S, Landry G, Kurz C Journal article Proton dose calculation with LSTM networks in presence of a magnetic field (2024) Radonic D, Xiao F, Wahl N, Voss L, Neishabouri A, Delopoulos N, Marschner S, et al. Journal article Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group (2024) Elsayad K, Guenova E, Assaf C, Nicolay JP, Trautinger F, Stadler R, Waldstein C, et al. Journal article, Review article Semi-automated reproducible target transfer for cardiac radioablation – A multi-center cross-validation study within the RAVENTA trial (2024) Hohmann S, Xie J, Eckl M, Grehn M, Karfoul N, Janorschke C, Merten R, et al. Journal article Pembrolizumab and radiochemotherapy in locally advanced cervical cancer-the prospective, randomised KEYNOTE-A18 phase 3 study Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie (2024) Trommer M, Gaasch A, Corradini S Journal article Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation (2024) Ümütlü MR, Öcal O, Puhr-Westerheide D, Fabritius MP, Wildgruber M, Deniz S, Corradini S, et al. Journal article Re-irradiation treatment regimens for patients with recurrent glioma – Evaluation of the optimal dose and best concurrent therapy (2024) Fleischmann DF, Gajdi L, Corradini S, Schönecker S, Marschner S, Bodensohn R, Hofmaier J, et al. Journal article